Cabaletta Bio Inc (CABA)

Jan 30, 2025

Cabaletta Bio to Present at Guggenheim’s SMID Cap Biotech Conference - MSN

Jan 30, 2025

Jan 29, 2025

Cabaletta Bio to Participate in Guggenheim's SMID Cap Biotech Conference - The Manila Times

Jan 29, 2025

Jan 29, 2025

Cabaletta Bio to Participate in Guggenheim’s SMID Cap Biotech Conference - GlobeNewswire Inc.

Jan 29, 2025

Jan 25, 2025

Cabaletta Bio, Inc. (NASDAQ:CABA) Holdings Decreased by JPMorgan Chase & Co. - Defense World

Jan 25, 2025

Jan 25, 2025

JPMorgan Chase & Co. Has $1.32 Million Holdings in Cabaletta Bio, Inc. (NASDAQ:CABA) - MarketBeat

Jan 25, 2025

Jan 24, 2025

Analysts Set Expectations for Cabaletta Bio FY2025 Earnings - Defense World

Jan 24, 2025

Jan 23, 2025

Brokers Issue Forecasts for Cabaletta Bio FY2025 Earnings - MarketBeat

Jan 23, 2025

Jan 21, 2025

Barclays PLC Buys 19,891 Shares of Cabaletta Bio, Inc. (NASDAQ:CABA) - Defense World

Jan 21, 2025

Jan 20, 2025

Cabaletta Bio Discloses Unaudited Cash and Cash Equivalents of $164 Million as of December 31, 2024 - Defense World

Jan 20, 2025

Jan 19, 2025

HC Wainwright Reaffirms “Buy” Rating for Cabaletta Bio (NASDAQ:CABA) - Defense World

Jan 19, 2025

Jan 18, 2025

Cabaletta Bio (NASDAQ:CABA) Earns "Buy" Rating from HC Wainwright - MarketBeat

Jan 18, 2025

Jan 18, 2025

Brokerages Set Cabaletta Bio, Inc. (NASDAQ:CABA) PT at $24.38 - MarketBeat

Jan 18, 2025

Jan 18, 2025

Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Average Recommendation of “Buy” from Brokerages - Defense World

Jan 18, 2025

Jan 18, 2025

Cabaletta Bio Advances Autoimmune Therapy, Sets Strategic Goals for 2025 - MSN

Jan 18, 2025

Jan 17, 2025

Cabaletta Bio stock maintain buy rating on trial progress By Investing.com - Investing.com Canada

Jan 17, 2025

Jan 17, 2025

Cabaletta Bio's (CABA) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Jan 17, 2025

Jan 17, 2025

Cabaletta Bio stock maintain buy rating on trial progress - Investing.com

Jan 17, 2025

Jan 13, 2025

Cabaletta Bio Advances Clinical Trials with Lonza Partnership - TipRanks

Jan 13, 2025

Jan 13, 2025

Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025 - The Manila Times

Jan 13, 2025

Jan 10, 2025

A Look At The Behavior Of Hut 8 Corp (HUT) Stock - Stocks Register

Jan 10, 2025

Jan 06, 2025

Cabaletta Bio: Finding Optimism In Dire Straits (NASDAQ:CABA) - Seeking Alpha

Jan 06, 2025

Jan 06, 2025

Barclays PLC Has $288,000 Stake in Cabaletta Bio, Inc. (NASDAQ:CABA) - Defense World

Jan 06, 2025

Jan 06, 2025

Looking Into Cabaletta Bio's Recent Short Interest - Benzinga

Jan 06, 2025

Jan 05, 2025

Geode Capital Management LLC Raises Stock Holdings in Cabaletta Bio, Inc. (NASDAQ:CABA) - Defense World

Jan 05, 2025

Jan 03, 2025

Jane Street Group LLC Lowers Holdings in Cabaletta Bio, Inc. (NASDAQ:CABA) - Defense World

Jan 03, 2025

Dec 30, 2024

Short Interest in Cabaletta Bio, Inc. (NASDAQ:CABA) Rises By 38.2% - MarketBeat

Dec 30, 2024

Dec 30, 2024

State Street Corp Sells 1,109,678 Shares of Cabaletta Bio, Inc. (NASDAQ:CABA) - Defense World

Dec 30, 2024

Dec 30, 2024

Cabaletta Bio, Inc. (NASDAQ:CABA) Shares Sold by State Street Corp - MarketBeat

Dec 30, 2024

Dec 24, 2024

Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Consensus Rating of “Buy” from Analysts - Defense World

Dec 24, 2024

Dec 24, 2024

Cabaletta Bio, Inc. (NASDAQ:CABA) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Dec 24, 2024

Dec 22, 2024

Cabaletta Bio (NASDAQ:CABA) Stock Rating Lowered by Evercore ISI - Defense World

Dec 22, 2024

Dec 20, 2024

Cabaletta Bio's SWOT analysis: autoimmune CAR-T stock faces challenges, opportunities By Investing.com - Investing.com South Africa

Dec 20, 2024

Dec 20, 2024

Cabaletta Bio's SWOT analysis: autoimmune CAR-T stock faces challenges, opportunities - Investing.com

Dec 20, 2024

Dec 20, 2024

Cabaletta Bio (NASDAQ:CABA) Downgraded by Evercore ISI to "Inline" - MarketBeat

Dec 20, 2024

Dec 19, 2024

Wells Fargo Downgrades Cabaletta Bio (CABA) - MSN

Dec 19, 2024

Dec 19, 2024

Charles Schwab Investment Management Inc. Raises Stake in Cabaletta Bio, Inc. (NASDAQ:CABA) - Defense World

Dec 19, 2024

Dec 19, 2024

This C3.ai Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday - Benzinga

Dec 19, 2024

Dec 19, 2024

Cabaletta Bio (NASDAQ:CABA) Downgraded to Equal Weight Rating by Wells Fargo & Company - MarketBeat

Dec 19, 2024

Dec 17, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Holdings in Cabaletta Bio, Inc. (NASDAQ:CABA) - Defense World

Dec 17, 2024

Dec 15, 2024

Cabaletta Bio's SWOT analysis: CAR-T pioneer's stock faces pivotal moment - Investing.com

Dec 15, 2024

Dec 10, 2024

Cabaletta Bio, Inc.'s (NASDAQ:CABA) latest 25% decline adds to one-year losses, institutional investors may consider drastic measures - Yahoo Finance

Dec 10, 2024

Dec 10, 2024

Is Cabaletta Bio (NASDAQ:CABA) In A Good Position To Invest In Growth? - Simply Wall St

Dec 10, 2024

Dec 10, 2024

Point72 Asset Management L.P. Makes New $3.15 Million Investment in Cabaletta Bio, Inc. (NASDAQ:CABA) - MarketBeat

Dec 10, 2024

Dec 06, 2024

Jennison Associates LLC Reduces Stake in Cabaletta Bio Inc - GuruFocus.com

Dec 06, 2024

Dec 06, 2024

PRUDENTIAL FINANCIAL INC's Strategic Acquisition of Cabaletta Bi - GuruFocus.com

Dec 06, 2024

Dec 05, 2024

Walleye Capital LLC Acquires 212,025 Shares of Cabaletta Bio, Inc. (NASDAQ:CABA) - MarketBeat

Dec 05, 2024

Dec 03, 2024

Cabaletta Bio to Present Key Findings on CABA-201 at ACR Convergence 2024 - MSN

Dec 03, 2024

Dec 03, 2024

Weekly Analysts’ Ratings Updates for Cabaletta Bio (CABA) - Defense World

Dec 03, 2024

Dec 02, 2024

Unusually active option classes on open December 2nd - TipRanks

Dec 02, 2024

Dec 01, 2024

Cabaletta Bio (NASDAQ:CABA) Raised to Strong-Buy at TD Cowen - Defense World

Dec 01, 2024

Nov 30, 2024

Cabaletta Bio Sees Unusually High Options Volume (NASDAQ:CABA) - MarketBeat

Nov 30, 2024